Aska Pharmaceutical Co., Ltd.
Records under this name other than the patents Aska Pharmaceutical Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 21 patents it holds.
Back to Aska Pharmaceutical Co., Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,980,872 | Agent for Preventing And/Or Treating Functional Gastrointestinal Disorder Formerly held In force · High confidence | In force | High confidence | |
| US 10,632,065 | Microneedle device containing recombinant follicle stimulating hormone Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,829,000 | Substituted Imidazo[1,5-a]quinoxalines as Phosphodiesterase 9 Inhibitors Lapsed on the fee record Ended Sep 9, 2026 · High confidence | Lapsed on the fee record | Ended Sep 9, 2026 | High confidence |
| US 8,748,437 | Crystal of 2-(3,4 dichlorobenzyl)-5-methyl-4-oxo-3,4-dihydrothien[2,3-D]pyrimidine-6-carboxylic acid Lapsed on the fee record Ended Jun 10, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jun 10, 2026 | From the USPTO record |
| US 8,377,944 | Thienopyrimidine derivatives Lapsed on the fee record Ended Feb 19, 2025 · From the USPTO record | Lapsed on the fee record | Ended Feb 19, 2025 | From the USPTO record |
| US 7,339,022 | Peptide Fragment of LYVE-1 and Antibody Against the Same Formerly held Term ended Term ended Mar 11, 2024 · High confidence | Term ended | Term ended Mar 11, 2024 | High confidence |
| US 7,939,536 | Pyrimidinylisoxazole derivatives Lapsed on the fee record Ended May 10, 2023 · From the USPTO record | Lapsed on the fee record | Ended May 10, 2023 | From the USPTO record |
| US 7,799,775 | Pyrimidine derivatives Lapsed on the fee record Ended Sep 21, 2022 · From the USPTO record | Lapsed on the fee record | Ended Sep 21, 2022 | From the USPTO record |
| US 7,098,027 | Method for remyelinating a demyelinized lesion due to injury in the brain or spinal cord Formerly held Term ended Term ended Nov 24, 2021 · From the USPTO record | Term ended | Term ended Nov 24, 2021 | From the USPTO record |
| US 7,608,716 | Pyrazolonaphthyridine derivative Lapsed on the fee record Ended Oct 27, 2021 · From the USPTO record | Lapsed on the fee record | Ended Oct 27, 2021 | From the USPTO record |